SOURCE: Bilcare Global Clinical Supplies

February 26, 2008 12:25 ET

Bilcare Global Clinical Supplies Appoints Vito Mangiardi as New CEO

PUNE, INDIA--(Marketwire - February 26, 2008) - Bilcare Global Clinical Supplies, [] the single source provider of quality clinical trial materials from formulation and analytical services to IVRS and global distribution spread across the Americas, Europe and Asia, has appointed Vito Mangiardi, a 30-year Industry veteran as the new CEO to lead the firm.

Speaking on this momentous occasion, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Ltd., said, "Vito is an exceptional leader and strategist. He has vast experience in global business management, pharmaceutical and biotech contract research and development services, and extensive expertise in clinical supplies. Vito's breadth and depth of experience is unsurpassed in the industry and he is a perfect fit for Bilcare GCS as we continue to experience steady growth."

According to Mangiardi, "This is an honor and tremendous opportunity for me to add value to this booming enterprise."

Mangiardi has gained a wealth of experience in virtually all aspects of the clinical supplies, pharmaceutical and biotech industries. He has held key leadership positions throughout his career, most recently serving as President of North American Operations for AAI Pharma where he was responsible for Phase I, formulation development, analytical development, bio-analytical, manufacturing and stability testing, as well as Phase II-IV clinical trials. At AAI, Mangiardi grew the revenue line dramatically and turned the company results from a loss to a profit within two years.

Prior to his joining AAI Pharma, Mangiardi had a very successful career at Quintiles Transnational as a Senior Vice President and Chief Operating Officer of Global Phase IV Services. He also held other executive level positions at Quintiles including head of the International Clinical Development Services group in Japan, head of the Asia Pacific Business and Executive Vice President of Operational Services of Quintiles Americas. Mangiardi has also served as President and CEO of Clingenix, Inc., an early stage pharmacogenomics company, and as President and CEO of Diagnostic Laboratories.

The addition of Mangiardi's expertise in pharmaceutical, biotech and clinical supplies and services is another key element of a major global initiative that Bilcare GCS started in 2007. The initiative was undertaken to allow the company to provide a higher level of quality and service to its customers. During the last several months, the company has made substantial improvements globally including upgrading equipment, increasing the number of its state-of-the-art packaging rooms, expanding its storage and distribution facilities, enhancing its formulation and analytical development services and technical capabilities, and integrating global operations.

Other key milestones in the global initiative were Bilcare's recent announcement of its commitment to invest GBP 11million into a state-of-the art clinical supplies facility in South Wales and the inauguration of the Bilcare Centre of Excellence in Pune, India. Wales is an ideal location for Bilcare GCS to service the European market at a competitive cost. It will strengthen what is already a key location geographically and strategically for Bilcare GCS. The Centre of Excellence in India will have dedicated R&D sections for Packaging Research, Material Research, Analytical Research, Drug Sensitivity Studies and Package Design.

To maximize the effectiveness of its capital campaign, Bilcare GCS also made significant additions to its global management team. Reporting to Mangiardi are three well respected industry veterans, David Laskow Pooley leading the company's European operations, Vincent Santa Maria leading the American operations and Ajit Dubhashi leading the Asian operations. The company also added key management personnel globally in Sales, IT, IVRS, Project Management, Business Development, Operations, Formulation, Analytical Services and Finance.

Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with clinical trial materials support, services and complete project management. Our services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical trial materials (CTM) satisfy a broad range of requirements; from pre-formulation research and development, analytical services and clinical supplies packaging and labeling, to IVRS, controlled temperature (cold and frozen chain) CTM storage, distribution worldwide, and returns and destructions accountability.

For more information about Bilcare Global Clinical Supplies, please visit our website at

Contact Information

  • For more information, contact:

    Corporate Information Contact :
    Jaydip Chowdhury
    Head Corporate Communications
    Email Contact